NCT01479959

Brief Summary

Adequate communication is a major part of the quality of life of tracheostomized ventilator dependent patients. Maintaining speech is therefore major goal in the management of these patients. The use of a positive end-expiratory pressure (PEEP) during ventilation has allowed the improvement of speech. The best level for speech may vary from one patient to the other The purpose of this study is to determine individually the most efficient PEEP level in terms of speech while obtaining the most secure condition and the best possible respiratory tolerance. In order to improve the latter, the investigators will use a device which allows the patients to control the activation of PEEP so that they can use it only when needed (i.e. when they wish to speak). The investigators will compare the effect of different PEEP level to try to determine the best compromise to improve speech in tracheostomized ventilator-dependent patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2011

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 28, 2011

Completed
Last Updated

November 28, 2011

Status Verified

November 1, 2011

Enrollment Period

1.1 years

First QC Date

November 17, 2011

Last Update Submit

November 22, 2011

Conditions

Keywords

Tracheostomypositive end expiratory pressurespeechrespiratory failureventilationneuromuscular disorders

Outcome Measures

Primary Outcomes (1)

  • Efficiency of PEEP level on speech

    Measurement of the duration of a text passage reading, the maximal phonation time throughout the repsiratory cycle.

    20 minutes

Secondary Outcomes (4)

  • Effect of PEEP level on voice quality

    20 minutes

  • Respiratory Comfort evaluated with a visual analogic scale by patients

    20 minutes

  • Respiratory tolerance

    20 minute

  • Use of PEEP control switch

    20 minutes

Study Arms (3)

No PEEP level

ACTIVE COMPARATOR

protocol conducted while no PEEP is applied

Device: Eole 3 ventilator - Resmed

effective PEEP level (PEEPeff)

ACTIVE COMPARATOR

PEEP level allowing the entire expiratory volume to go through the upper airways during quiet breathing

Device: Eole 3 ventilator - Resmed

intermediate PEEP level (PEEP50)

ACTIVE COMPARATOR

50% of PEEPeff

Device: Eole 3 ventilator - Resmed

Interventions

positive end expiratory pressure is added to the ventilation mode and it is activated by a switch under patient's control

Also known as: Goodnight 420E, Tyco Healthcare, Puritan Bennett
No PEEP leveleffective PEEP level (PEEPeff)intermediate PEEP level (PEEP50)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient
  • Neuromuscular patients, tracheostomized and on long term ventilation with a cuffless tube
  • Assist control volumetric ventilation mode
  • Signed consent form

You may not qualify if:

  • Pregnancy
  • Patients unable to read
  • Acute respiratory failure
  • Contra-indication of PEEP use
  • Lack of social security coverage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Raymond Poincare

Garches, 92380, France

Location

Related Publications (7)

  • Prigent H, Samuel C, Louis B, Abinun MF, Zerah-Lancner F, Lejaille M, Raphael JC, Lofaso F. Comparative effects of two ventilatory modes on speech in tracheostomized patients with neuromuscular disease. Am J Respir Crit Care Med. 2003 Jan 15;167(2):114-9. doi: 10.1164/rccm.200201-026OC. Epub 2002 Oct 4.

    PMID: 12406841BACKGROUND
  • Prigent H, Garguilo M, Pascal S, Pouplin S, Bouteille J, Lejaille M, Orlikowski D, Lofaso F. Speech effects of a speaking valve versus external PEEP in tracheostomized ventilator-dependent neuromuscular patients. Intensive Care Med. 2010 Oct;36(10):1681-1687. doi: 10.1007/s00134-010-1935-0. Epub 2010 Jun 10.

    PMID: 20535605BACKGROUND
  • Pellegrini N, Pelletier A, Orlikowski D, Lolierou C, Ruquet M, Raphael JC, Lofaso F. Hand versus mouth for call-bell activation by DMD and Becker patients. Neuromuscul Disord. 2007 Jul;17(7):532-6. doi: 10.1016/j.nmd.2007.03.016. Epub 2007 May 29.

    PMID: 17533130BACKGROUND
  • Bach JR, Alba AS. Tracheostomy ventilation. A study of efficacy with deflated cuffs and cuffless tubes. Chest. 1990 Mar;97(3):679-83. doi: 10.1378/chest.97.3.679.

    PMID: 2407453BACKGROUND
  • Hoit JD, Banzett RB, Lohmeier HL, Hixon TJ, Brown R. Clinical ventilator adjustments that improve speech. Chest. 2003 Oct;124(4):1512-21. doi: 10.1378/chest.124.4.1512.

    PMID: 14555587BACKGROUND
  • Hoit JD, Shea SA, Banzett RB. Speech production during mechanical ventilation in tracheostomized individuals. J Speech Hear Res. 1994 Feb;37(1):53-63. doi: 10.1044/jshr.3701.53.

    PMID: 8170131BACKGROUND
  • Garguilo M, Leroux K, Lejaille M, Pascal S, Orlikowski D, Lofaso F, Prigent H. Patient-controlled positive end-expiratory pressure with neuromuscular disease: effect on speech in patients with tracheostomy and mechanical ventilation support. Chest. 2013 May;143(5):1243-1251. doi: 10.1378/chest.12-0574.

MeSH Terms

Conditions

SpeechRespiratory InsufficiencyRespiratory AspirationNeuromuscular Diseases

Condition Hierarchy (Ancestors)

Verbal BehaviorCommunicationBehaviorRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsNervous System Diseases

Study Officials

  • Helene PRIGENT, MD

    Hôpital Raymond Poincaré - APHP

    PRINCIPAL INVESTIGATOR
  • Frederic LOFASO, MD-PhD

    University of Versailles

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Helene PRIGENT MD

Study Record Dates

First Submitted

November 17, 2011

First Posted

November 28, 2011

Study Start

June 1, 2010

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

November 28, 2011

Record last verified: 2011-11

Locations